RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
ACRO Biomedical Co Stock

ACRO Biomedical Co P/S 2024

ACRO Biomedical Co P/S

382.07

Ticker

ACBM

ISIN

US0048921052

As of Jul 29, 2024, ACRO Biomedical Co's P/S ratio stood at 382.07, a 221.34% change from the 118.9 P/S ratio recorded in the previous year.

The ACRO Biomedical Co P/S history

ACRO Biomedical Co Aktienanalyse

What does ACRO Biomedical Co do?

ACRO Biomedical Co Ltd is a leading company in biomedical technology based in Taipei, Taiwan. The company was established in 2006 and has since successfully established itself in the global market for biomedical products and technologies. The company's vision is to improve people's lives and promote health worldwide through innovative and high-quality products and solutions. Business model: ACRO Biomedical Co Ltd specializes in the development, manufacturing, and marketing of biomedical products and technologies. The company has three main divisions: Regenerative Medicine, Wound Care, and Surgical Technology. Each division focuses on developing products and solutions tailored to the needs of patients and medical professionals. Regenerative Medicine: ACRO Biomedical Co Ltd is a leading provider of regenerative biomedical products. Under this division, the company develops innovative solutions for tissue regeneration, such as bioimplants made from natural tissues and biomaterials to repair or restore damaged tissue. These products are used for the treatment of injuries, chronic diseases, and degenerative conditions. Additionally, ACRO Biomedical Co Ltd has also developed solutions for cosmetic and aesthetic applications. Wound Care: ACRO Biomedical Co Ltd's wound care division specializes in developing products and solutions that help accelerate wound healing, prevent infections, and reduce the risk of complications. The company offers a wide range of products, including antimicrobial and moist wound dressings, which are used for the treatment of acute and chronic wounds such as burns, abrasions, and diabetic foot ulcers. Surgical Technology: ACRO Biomedical Co Ltd's surgical technology division provides healthcare professionals with a wide range of surgical products for various applications, including neurosurgery, plastic surgery, and general surgery. The innovative products offered by ACRO Biomedical Co Ltd for surgical applications include cutting tools, implants, and instruments for minimally invasive procedures. Products: ACRO Biomedical Co Ltd offers a wide range of products for various applications and medical specialties. Some of the company's key products include: - ACL-Bioimplant: A bioimplant for cruciate ligament repair made from human cartilage and biomaterials. - ACRO-CAF: A bone grafting material for bone transplantation. - ACRO-Mixtop: A wound healing agent for the treatment of burns, abrasions, and chronic wounds. - ACRO-OSTEOT: A surgical bone drill for orthopedics and neurosurgery. - ACRO-BioSIS: A tissue adhesive for surgical applications. Summary: ACRO Biomedical Co Ltd is a leading company in biomedical technology that offers innovative solutions for the preservation and restoration of people's health. With its three main divisions: Regenerative Medicine, Wound Care, and Surgical Technology, the company provides a wide range of products and solutions for medical professionals and patients. The company's products are marketed worldwide and are known for their quality, reliability, and effectiveness. ACRO Biomedical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding ACRO Biomedical Co's P/S Ratio

ACRO Biomedical Co's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing ACRO Biomedical Co's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating ACRO Biomedical Co's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in ACRO Biomedical Co’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about ACRO Biomedical Co stock

What is the price-to-earnings ratio of ACRO Biomedical Co?

The price-earnings ratio of ACRO Biomedical Co is currently 382.07.

How has the price-earnings ratio of ACRO Biomedical Co changed compared to last year?

The price-to-earnings ratio of ACRO Biomedical Co has increased by 221.34% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of ACRO Biomedical Co high compared to other companies?

Yes, the price-to-earnings ratio of ACRO Biomedical Co is high compared to other companies.

How does an increase in the price-earnings ratio of ACRO Biomedical Co affect the company?

An increase in the price-earnings ratio of ACRO Biomedical Co would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of ACRO Biomedical Co affect the company?

A decrease in the price-earnings ratio of ACRO Biomedical Co would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of ACRO Biomedical Co?

Some factors that influence the price-earnings ratio of ACRO Biomedical Co are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does ACRO Biomedical Co pay?

Over the past 12 months, ACRO Biomedical Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ACRO Biomedical Co is expected to pay a dividend of 0 USD.

What is the dividend yield of ACRO Biomedical Co?

The current dividend yield of ACRO Biomedical Co is .

When does ACRO Biomedical Co pay dividends?

ACRO Biomedical Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of ACRO Biomedical Co?

ACRO Biomedical Co paid dividends every year for the past 0 years.

What is the dividend of ACRO Biomedical Co?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is ACRO Biomedical Co located?

ACRO Biomedical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von ACRO Biomedical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ACRO Biomedical Co from 7/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/29/2024.

When did ACRO Biomedical Co pay the last dividend?

The last dividend was paid out on 7/29/2024.

What was the dividend of ACRO Biomedical Co in the year 2023?

In the year 2023, ACRO Biomedical Co distributed 0 USD as dividends.

In which currency does ACRO Biomedical Co pay out the dividend?

The dividends of ACRO Biomedical Co are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von ACRO Biomedical Co

Our stock analysis for ACRO Biomedical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ACRO Biomedical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.